EGFR and lung carcinoma: In addition, Shien et al. (2013) demonstrated that a lung cancer cell line with acquired resistance to an EGFR tyrosine kinase inhibitor exhibited EMT features and the downregulation of mir-200c as a result of DNA methylation.